MRSA and Antibiotic Resistant Infection Treatment in Northwest Arkansas
When standard antibiotics fail, our infectious disease physicians have the expertise to identify alternatives and design effective treatment.
What Antibiotic Resistance Is and Why Specialist Care Matters
Antibiotic resistance occurs when bacteria evolve mechanisms that defeat the medications designed to kill them. The same is true of fungi and antifungal medications. When a resistant organism causes infection, the usual first line drugs do not work, and the wrong choice of treatment can let the infection worsen. Infectious disease specialists are trained to interpret culture and susceptibility data, recognize regional resistance patterns, and select alternative antibiotics that the organism is still sensitive to. We also know which combinations of drugs work synergistically and which to avoid, and we keep current with new agents as they reach the market.
Common Resistant Organisms We Treat
Methicillin resistant Staphylococcus aureus, commonly called MRSA, is one of the most well known resistant bacteria and causes skin, soft tissue, bone, joint, and bloodstream infections. Vancomycin resistant Enterococcus (VRE) often complicates urinary tract and bloodstream infections in patients with prior hospitalization. ESBL producing E. coli and Klebsiella resist many oral antibiotics and often require IV treatment. Carbapenem resistant Enterobacteriaceae (CRE) are highly resistant and require careful selection of newer antibiotics. We also treat drug resistant Candida species, multidrug resistant tuberculosis, and resistant Pseudomonas and Acinetobacter.
Why First Line Antibiotics Fail and What Comes Next
Antibiotics fail for several reasons. The organism may be intrinsically resistant to the drug class. The patient may have a deep seated infection where the antibiotic does not reach an effective concentration. Devices like joint replacements and heart valves harbor biofilms that protect bacteria from many drugs. Past antibiotic exposure can select for resistant strains. When first line treatment is not working, we obtain repeat cultures, review susceptibility results, image any potential abscess or device involvement, and choose a regimen targeted at the specific organism and site of infection. Sometimes source control with surgery or drainage is also needed.
Treatment Strategies Including Combination Therapy and IV
Treating resistant infections often requires more than one antibiotic. Combination therapy can broaden coverage during the initial period before culture results are available, target organisms that have multiple resistance mechanisms, or take advantage of synergistic effects between drugs. Many resistant infections require intravenous antibiotics for at least part of the course. Newer oral agents have expanded our options, but they should be chosen by a specialist familiar with the latest data. Our practice has access to the full range of approved antibiotics and antifungals and the experience to design treatment that maximizes cure while minimizing toxicity.
Prevention and Ongoing Monitoring
Once a patient has had a resistant infection, ongoing monitoring is important because relapse and reinfection can occur. We schedule follow up visits and labs based on the type of infection, the duration of treatment, and the patient's overall health. We also coordinate decolonization protocols for patients with recurrent MRSA, review household exposure risks, and counsel on hygiene measures that reduce the spread of resistant organisms within a family. For patients with chronic medical conditions or implanted devices, we develop a long term plan to reduce the chance of future resistant infections.
Common Questions from Our Patients
Do I need a referral to be evaluated for a resistant infection?
Most patients with resistant infections are referred by their primary care physician, a hospital, or a surgeon, because the infection has usually been identified through cultures during prior care. A formal referral is helpful because it gives us the diagnosis, culture results, and previous treatments. If you suspect you have a resistant infection but have not been referred, call our office and we will guide you through scheduling and what records to bring.
How long does treatment take?
Duration depends on the type and location of the infection. Skin and soft tissue infections may need one to two weeks. Bone, joint, and prosthetic device infections often require six weeks or more. Bloodstream infections vary from two to six weeks. Some patients with chronic infections may need longer suppressive therapy. We provide a clear estimate at the start and update it as treatment progresses based on lab results, imaging, and your clinical response.
Can a resistant infection come back?
Recurrence is possible, and the risk depends on the organism, the site of infection, the success of source control, and your overall health. We watch for relapse with follow up labs and clinical visits after treatment ends. Patients with prosthetic devices, chronic wounds, or compromised immune systems are at higher risk and may benefit from longer monitoring. If you develop new symptoms after treatment, contact us promptly so we can evaluate and act early if needed.
Is my family at risk of catching a resistant infection from me?
Some resistant organisms can spread within households, particularly MRSA in skin and soft tissue infections. We discuss specific precautions based on the organism involved. General measures include thorough hand washing, not sharing towels or razors, keeping wounds covered, and washing bedding and clothing regularly. For most patients, family members are at low risk if these basic measures are followed. We provide written guidance for the household and answer questions about decolonization when appropriate.
How often will I need follow up?
During active treatment, visits are typically every one to two weeks with labs to monitor the antibiotic and the infection. After treatment ends, a single follow up visit four to six weeks later is common to confirm resolution. Patients with high risk infections like endocarditis or prosthetic device infection may need longer follow up at three, six, and twelve months. We tailor the schedule to your specific situation and adjust based on how you are doing.